tiprankstipranks
Trending News
More News >
Emimen Co.,Ltd. (JP:9237)
:9237
Japanese Market

Emimen Co.,Ltd. (9237) AI Stock Analysis

Compare
0 Followers

Top Page

JP:9237

Emimen Co.,Ltd.

(9237)

Select Model
Select Model
Select Model
Neutral 60 (OpenAI - 5.2)
Rating:60Neutral
Price Target:
¥1,050.00
▼(-51.72% Downside)
Action:DowngradedDate:01/14/26
The score is supported primarily by improved financial health and strong top-line growth, but is held back by the 2025 margin/cash-flow deterioration. Technicals are currently bearish (below key moving averages with negative MACD), and valuation looks demanding with a high P/E and no dividend data.
Positive Factors
Revenue Growth
A large, sustained top-line expansion increases market share and gives the company scope to invest in capabilities and fixed-cost absorption. Multi-year revenue scaling supports long-run competitiveness and revenue diversification, improving strategic optionality even if margins fluctuate.
Balance Sheet Health
Material reduction in leverage and a stronger equity base materially raise financial resilience. Low debt levels reduce refinancing and interest risk, allowing management to fund growth or weather downturns without immediate external financing, a durable structural strength.
Consistent Free Cash Flow
Multi-year positive free cash flow indicates the business can generate internal funding for capex, working capital, or debt reduction. Persistent cash generation underpins sustainable operations and reduces dependence on equity raises, supporting long-term strategic investments.
Negative Factors
Margin Compression
A sharp, persistent fall in margins erodes profitability and return on capital. Lower margins reduce the buffer for operating shocks, constrain reinvestment capacity, and increase sensitivity to input cost inflation, making long-term earnings less reliable without margin recovery.
Weaker Cash Conversion
A meaningful decline in cash-to-profit quality reduces internally available funds for growth and deleveraging. If cash conversion stays depressed, the company may need external financing or be forced to cut investments, weakening sustainable growth and increasing financial vulnerability.
Historical Leverage Episodes
Prior periods of high leverage show the balance sheet can deteriorate rapidly when profits fall. This legacy risk means the current low-leverage position depends on maintaining profitability; cyclical or structural profit pressures could quickly reintroduce solvency risk.

Emimen Co.,Ltd. (9237) vs. iShares MSCI Japan ETF (EWJ)

Emimen Co.,Ltd. Business Overview & Revenue Model

Company DescriptionEmimen Co., Ltd. provides senior home introduction services for the elderly in Japan. It offers support services for moving into senior homes and information on senior homes; and senior home management consulting services, such as care prime community site management and new senior home opening consulting. The company was incorporated in 2010 and is headquartered in Osaka, Japan.
How the Company Makes MoneyEmimen Co., Ltd. generates revenue primarily through the sale of telecommunications equipment and software solutions to both enterprise clients and consumers. The company has established key partnerships with major telecommunications providers, enabling it to offer integrated systems that enhance network performance and reliability. Additional revenue streams include maintenance and support services, as well as licensing fees from proprietary software. The company's focus on innovation and the development of smart devices also contributes to its earnings, as it taps into the growing market for IoT (Internet of Things) solutions and related technologies.

Emimen Co.,Ltd. Financial Statement Overview

Summary
Strong revenue growth and a multi-year turnaround to profitability, plus a much healthier, low-leverage balance sheet. Offsetting this, 2025 saw a sharp margin and net income step-down and weaker cash conversion (free cash flow ~61% of net income), increasing near-term earnings quality risk.
Income Statement
72
Positive
Revenue has scaled rapidly over the past several years, accelerating sharply in 2025 (annual revenue up ~119%). Profitability improved materially from 2021 losses to solid profits in 2022–2024, but 2025 shows a notable step-down in earnings power: net margin fell to ~4.8% (vs. ~13.8% in 2024) and operating margin also compressed meaningfully. Strength is strong top-line momentum; key weakness is the sharp margin and net income decline in the latest year.
Balance Sheet
82
Very Positive
Leverage has improved dramatically versus 2021–2022 when equity was very small and debt levels looked elevated relative to equity. By 2023–2025, the balance sheet appears much healthier with low debt versus equity (debt-to-equity ~0.15–0.29) and expanding equity base alongside asset growth. Return on equity remains positive in recent years (though it moderated in 2025), suggesting profits are still supporting capital. Main risk: the business has a history of very high leverage during weaker periods, so maintaining profitability is important to keep the balance sheet strong.
Cash Flow
58
Neutral
Cash generation was strong in 2022–2024, with free cash flow generally close to net income and positive growth. However, 2025 shows weaker cash conversion: operating cash flow dropped to ~¥76.8M and free cash flow to ~¥47.1M, with free cash flow covering only ~61% of net income (down from ~89% in 2024). Strength is consistently positive free cash flow in recent years; weakness is the 2025 deterioration in operating cash flow and cash-to-profit quality.
BreakdownTTMOct 2025Oct 2024Oct 2023Oct 2022Oct 2021
Income Statement
Total Revenue855.65M1.87B1.30B814.29M609.70M429.92M
Gross Profit29.27M935.85M916.68M581.74M391.10M267.53M
EBITDA33.42M124.13M220.70M102.39M26.66M-74.29M
Net Income38.28M89.67M179.65M105.96M35.02M-78.53M
Balance Sheet
Total Assets1.21B1.38B1.13B788.68M312.05M271.42M
Cash, Cash Equivalents and Short-Term Investments766.16M657.26M761.02M590.56M192.99M191.44M
Total Debt103.59M125.53M116.23M135.58M147.65M177.88M
Total Liabilities448.53M564.34M407.97M324.30M273.05M267.43M
Stockholders Equity758.31M813.47M720.62M464.39M39.01M3.98M
Cash Flow
Free Cash Flow18.00M47.06M140.67M94.14M37.23M-80.75M
Operating Cash Flow24.00M76.77M158.14M104.83M38.29M-75.44M
Investing Cash Flow-14.00M-201.68M-44.61M-9.36M-6.34M-6.58M
Financing Cash Flow-5.50M13.96M56.94M303.11M-30.39M8.87M

Emimen Co.,Ltd. Technical Analysis

Technical Analysis Sentiment
Negative
Last Price2175.00
Price Trends
50DMA
884.58
Positive
100DMA
968.63
Negative
200DMA
1051.00
Negative
Market Momentum
MACD
2.81
Positive
RSI
46.68
Neutral
STOCH
25.24
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:9237, the sentiment is Negative. The current price of 2175 is above the 20-day moving average (MA) of 916.65, above the 50-day MA of 884.58, and above the 200-day MA of 1051.00, indicating a neutral trend. The MACD of 2.81 indicates Positive momentum. The RSI at 46.68 is Neutral, neither overbought nor oversold. The STOCH value of 25.24 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:9237.

Emimen Co.,Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
73
Outperform
¥3.78B-29.542.07%49.99%142.46%
71
Outperform
¥5.26B25.46283.85%-35.61%
64
Neutral
¥3.86B17.363.54%13.81%64.18%
63
Neutral
$10.79B15.437.44%2.01%2.89%-14.66%
60
Neutral
¥3.65B40.5743.89%-50.27%
55
Neutral
¥4.32B3.512.93%1.61%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:9237
Emimen Co.,Ltd.
897.00
-103.00
-10.30%
JP:3768
Riskmonster.Com
587.00
200.82
52.00%
JP:5867
ES Networks Co., Ltd.
1,230.00
275.49
28.86%
JP:6578
CORREC CO., LTD.
514.00
186.00
56.71%
JP:7034
Prored Partners Co., Ltd.
480.00
44.00
10.09%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jan 14, 2026